20
Participants
Start Date
January 31, 2014
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Octreotide
Octreotide 100mcg (1mL) single dose, subcutaneously, into the lower abdomen, 50 minutes prior to eating
Placebo
0.9% saline (1mL) single dose, subcutaneously, into the lower abdomen, 50 minutes prior to eating
Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital, Dublin
Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg
University College Dublin
OTHER
University of Dublin, Trinity College
OTHER
Göteborg University
OTHER
St. James's Hospital, Ireland
OTHER